These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26835701)

  • 1. Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system.
    Izmirly PM; Saxena A; Sahl SK; Shah U; Friedman DM; Kim MY; Buyon JP
    Ann Rheum Dis; 2016 Jun; 75(6):1161-5. PubMed ID: 26835701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus.
    Izmirly PM; Saxena A; Kim MY; Wang D; Sahl SK; Llanos C; Friedman D; Buyon JP
    Circulation; 2011 Nov; 124(18):1927-35. PubMed ID: 21969015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and treatment in utero of autoimmune-associated congenital heart block.
    Saxena A; Izmirly PM; Mendez B; Buyon JP; Friedman DM
    Cardiol Rev; 2014; 22(6):263-7. PubMed ID: 25050975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
    Mevorach D; Elchalal U; Rein AJ
    Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neonatal lupus syndrome: Literature review].
    Morel N; Georgin-Lavialle S; Levesque K; Guettrot-Imbert G; Le Guern V; Le Bidois J; Bessières B; Brouzes C; Le Mercier D; Villain E; Maltret A; Costedoat-Chalumeau N
    Rev Med Interne; 2015 Mar; 36(3):159-66. PubMed ID: 25240481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anatomical and pathological findings in hearts from fetuses and infants with cardiac manifestations of neonatal lupus.
    Llanos C; Friedman DM; Saxena A; Izmirly PM; Tseng CE; Dische R; Abellar RG; Halushka M; Clancy RM; Buyon JP
    Rheumatology (Oxford); 2012 Jun; 51(6):1086-92. PubMed ID: 22308531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndrome.
    Levesque K; Morel N; Maltret A; Baron G; Masseau A; Orquevaux P; Piette JC; Barriere F; Le Bidois J; Fermont L; Fain O; Theulin A; Sassolas F; Pezard P; Amoura Z; Guettrot-Imbert G; Le Mercier D; Georgin-Lavialle S; Deligny C; Hachulla E; Mouthon L; Ravaud P; Villain E; Bonnet D; Costedoat-Chalumeau N; ;
    Autoimmun Rev; 2015 Dec; 14(12):1154-60. PubMed ID: 26284740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus.
    Saleeb S; Copel J; Friedman D; Buyon JP
    Arthritis Rheum; 1999 Nov; 42(11):2335-45. PubMed ID: 10555029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, risk factors, and mortality of neonatal and late-onset dilated cardiomyopathy associated with cardiac neonatal lupus.
    Morel N; Lévesque K; Maltret A; Baron G; Hamidou M; Orquevaux P; Piette JC; Barriere F; Le Bidois J; Fermont L; Fain O; Theulin A; Sassolas F; Hauet Q; Guettrot-Imbert G; Georgin-Lavialle S; Deligny C; Hachulla E; Mouthon L; Le Jeunne C; Ravaud P; Le Mercier D; Romefort B; Villain E; Bonnet D; Costedoat-Chalumeau N;
    Int J Cardiol; 2017 Dec; 248():263-269. PubMed ID: 28843719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study.
    Rein AJ; Mevorach D; Perles Z; Gavri S; Nadjari M; Nir A; Elchalal U
    Circulation; 2009 Apr; 119(14):1867-72. PubMed ID: 19332471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing fetal cardiac conduction in anti-Ro/SSA-positive pregnancies.
    Sonesson SE; Hedlund M; Ambrosi A; Wahren-Herlenius M
    Rheumatology (Oxford); 2017 Oct; 56(10):1755-1762. PubMed ID: 28957562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal sonographic monitoring of progressive cardiac damages caused by anti-Ro antibodies: A case report.
    Tongprasert F; Sittiwangkul R; Lerthiranwong T; Tongsong T
    J Clin Ultrasound; 2018 Jun; 46(5):347-350. PubMed ID: 29023775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.
    Jaeggi E; Laskin C; Hamilton R; Kingdom J; Silverman E
    J Am Coll Cardiol; 2010 Jun; 55(24):2778-84. PubMed ID: 20538173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients.
    Eliasson H; Sonesson SE; Sharland G; Granath F; Simpson JM; Carvalho JS; Jicinska H; Tomek V; Dangel J; Zielinsky P; Respondek-Liberska M; Freund MW; Mellander M; Bartrons J; Gardiner HM;
    Circulation; 2011 Nov; 124(18):1919-26. PubMed ID: 21986286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupus.
    Izmirly P; Saxena A; Buyon JP
    Curr Opin Rheumatol; 2017 Sep; 29(5):467-472. PubMed ID: 28520682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options.
    Costedoat-Chalumeau N; Amoura Z; Villain E; Cohen L; Piette JC
    Arthritis Res Ther; 2005; 7(2):69-73. PubMed ID: 15743492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block.
    Costedoat-Chalumeau N; Georgin-Lavialle S; Amoura Z; Piette JC
    Lupus; 2005; 14(9):660-4. PubMed ID: 16218462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers.
    Izmirly P; Kim M; Friedman DM; Costedoat-Chalumeau N; Clancy R; Copel JA; Phoon CKL; Cuneo BF; Cohen RE; Robins K; Masson M; Wainwright BJ; Zahr N; Saxena A; Buyon JP
    J Am Coll Cardiol; 2020 Jul; 76(3):292-302. PubMed ID: 32674792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Umbilical cord blood levels of maternal antibodies reactive with p200 and full-length Ro 52 in the assessment of risk for cardiac manifestations of neonatal lupus.
    Reed JH; Clancy RM; Lee KH; Saxena A; Izmirly PM; Buyon JP
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1373-81. PubMed ID: 22511615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.